Peanut challenges prior to oral immunotherapy demonstrate high tolerance rates in selected patients

Background: Peanut oral immunotherapy (pOIT) protocols typically remain below the threshold for reaction during the initial dose escalation (IDE) day. However, some patients may have higher thresholds for reaction or may not have an ongoing peanut allergy. Objective: We sought to characterize the re...

Full description

Saved in:
Bibliographic Details
Main Authors: Candice N. Gard, MD, Georgiana M. Sanders, MD, MS, Ian F. Slack, MD, Charles F. Schuler, IV, MD, George E. Freigeh, MD, MA, Kelly M. O’Shea, MD
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Journal of Allergy and Clinical Immunology: Global
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772829325000438
Tags: Add Tag
No Tags, Be the first to tag this record!